Kf. Hubner et al., DIFFERENTIATING BENIGN FROM MALIGNANT LUNG LESIONS USING QUANTITATIVEPARAMETERS OF FDG PET IMAGES, Clinical nuclear medicine, 21(12), 1996, pp. 941-949
Fluorine-18 labeled deoxyglucose positron-emission tomography (FDG-PET
) applications in oncology include the differential diagnosis of chest
masses and single pulmonary nodules. However, FDG is not tumor-specif
ic; rather, it also accumulates in inflammatory processes. This study
was performed to identify image parameters that would improve the spec
ificity of PET. Methods: Twenty-six patients who had benign and malign
ant lung lesions were examined retrospectively. Positron-emission tomo
graphy data were acquired in dynamic scanning mode after intravenous b
olus of 250-402 MBq of FDG. Standardized uptake values (SUVs) were cal
culated and Patlak analyses were performed in selected regions of inte
rest in the PET images. Positron-emission tomography results were rela
ted to histological diagnosis (N = 49) or clinical follow-up (N = 3).
Results: The specificity and sensitivity of the original PET scan repo
rts, which was based on visual image interpretation and loosely applie
d SUVs, was 100% and 73%, respectively. Using the SUVs with a cut-off
value of 3.8 and Kpat value with a cut-off at 0.025 min(-1) improved t
he specificity to 81% and 85%. Conclusion: FDG-PET image interpretatio
n can be facilitated by using SUV information or the accumulation rate
of the radiotracer (Patlak). With additional validation, this method
could have a significant cost-effective impact on the medical/surgical
management of chest masses.